GB820474A - Improvements in or relating to liquid vitamin preparations - Google Patents

Improvements in or relating to liquid vitamin preparations

Info

Publication number
GB820474A
GB820474A GB29118/57A GB2911857A GB820474A GB 820474 A GB820474 A GB 820474A GB 29118/57 A GB29118/57 A GB 29118/57A GB 2911857 A GB2911857 A GB 2911857A GB 820474 A GB820474 A GB 820474A
Authority
GB
United Kingdom
Prior art keywords
cobalamin
vitamins
liquid
preparations
cyanocobalamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB29118/57A
Inventor
John Joseph Gulesich
George Morris Piersol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Priority to GB29118/57A priority Critical patent/GB820474A/en
Publication of GB820474A publication Critical patent/GB820474A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A liquid vitamin preparation comprises from 25 to 1500 micrograms % of a cobalamin vitamin, from 10 per cent w/v up to the limit of solubility but not in excess of 62% w/v of a polyhydric alcohol having the formula C6H14O6 and a liquid pharmaceutical vehicle. The preparations are said to provide higher serum levels of cobalamin vitamins than known preparations. Exemplary amongst the alcohols are sorbitol and mannitol. The cobalamin vitamins include cyanocobalamin, hydroxy cobalamin and anhydrous hydroxycobalamin, nitrocobalamin, chlorocobalamin, cobalamin, dicyanocobalamin, thiocyanocobalamin, sulphatocobalamin, sulphitocobalamin and the hydrogen sulphide addition product of cyanocobalamin. Other pharmaceutical agents may be included, e.g. folic acid, inositol, "B" vitamins, caffeine or a salt, betaine, choline, methiomine or ferric iron producing salts, e.g. ferric ammonium citrate, or soluble ferric pyrophosphate. The liquid vehicle is preferably aqueous, and in some cases may contain ethyl alcohol.
GB29118/57A 1957-09-16 1957-09-16 Improvements in or relating to liquid vitamin preparations Expired GB820474A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB29118/57A GB820474A (en) 1957-09-16 1957-09-16 Improvements in or relating to liquid vitamin preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB29118/57A GB820474A (en) 1957-09-16 1957-09-16 Improvements in or relating to liquid vitamin preparations

Publications (1)

Publication Number Publication Date
GB820474A true GB820474A (en) 1959-09-23

Family

ID=10286446

Family Applications (1)

Application Number Title Priority Date Filing Date
GB29118/57A Expired GB820474A (en) 1957-09-16 1957-09-16 Improvements in or relating to liquid vitamin preparations

Country Status (1)

Country Link
GB (1) GB820474A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767123A (en) * 1994-11-17 1998-06-16 Tanabe Seiyaku Co., Ltd. Total parenteral nutrition solution containing water-soluble vitamin B

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767123A (en) * 1994-11-17 1998-06-16 Tanabe Seiyaku Co., Ltd. Total parenteral nutrition solution containing water-soluble vitamin B

Similar Documents

Publication Publication Date Title
GB820474A (en) Improvements in or relating to liquid vitamin preparations
GB824908A (en) Improvements in or relating to triazine derivatives
GB821398A (en) Improvements in or relating to liquid vitamin preparation
GB1230413A (en)
GB1487543A (en) Dermatological composition
US2850429A (en) Liquid vitamin preparation
Fischer Metabolism of β-Methyl-C5 Fatty Acids by Mitochondria of Rat Liver: Effect of Biotin Nutriture.
GB858783A (en) Improvements in or relating to vitamin b compositions
GB1012585A (en) New compositions for use in acne and like conditions
AT207042B (en) Process for the production of pharmaceutical preparations which contain purines and / or purine derivatives
GB1184019A (en) Anorexigenic Compositions
Gaull Sulfur amino acids, folate and DNA: Metabolic interrelationships during foetal development
GB1356489A (en) Compositions for and method of combating coccidiosis and mareks disease in poultry
GB1235529A (en) Composition for mucolysis
GB1149318A (en) Anticoccidic composition
GB754364A (en) Improvements in medicinal preparations containing acetylsalicylic acid
GB780886A (en) Oral vitamin c preparations
GB1153767A (en) Improvements in or relating to Amitotic Therapeutic Composition Administrable by the Topical Route
GB1264509A (en)
GB1265104A (en)
GB731971A (en) Improvements in and relating to an aqueous solution of 4-dimethylaminoantipyrine andprocess for the preparation thereof
GB1222449A (en) Process for preparing pure human albumin from solutions containing haemopigments
USD226109S (en) Stylized model dragster
GB1252529A (en)
USD219231S (en) Model racing car